Showing results (271-280 of 301) with videos related to

Sort By:
Pageof 31
The Journal of Clinical Endocrinology and Metabolism|September 16, 2017
Assessment of VAV2 Expression Refines Prognostic Prediction in Adrenocortical CarcinomaSilviu Sbiera, Iuliu Sbiera, Carmen Ruggiero, et al.
Experimental Neurology|December 23, 2009
Human striatal neuroblasts develop and build a striatal-like structure into the brain of Huntington's disease patients after transplantationPasquale Gallina, Marco Paganini, Letizia Lombardini, et al.
International Journal of Alzheimer'S Disease|May 3, 2012
Risk and Determinants of Dementia in Patients with Mild Cognitive Impairment and Brain Subcortical Vascular Changes: A Study of Clinical, Neuroimaging, and Biological Markers-The VMCI-Tuscany Study: Rationale, Design, and MethodologyAnna Poggesi, Emilia Salvadori, Leonardo Pantoni, et al.
The Lancet. Oncology|December 7, 2017
European position statement on lung cancer screeningMatthijs Oudkerk, Anand Devaraj, Rozemarijn Vliegenthart, et al.
European Journal of Endocrinology|March 6, 2026
Clinical Predictors of Outcome in Advanced Adrenocortical Carcinoma: a multicentre international ENSAT studyAlessandra Mangone, Barbara Altieri, Emanuele Ferrante, et al.
Cell Communication and Signaling : CCS|March 4, 2025
Emerging role of IGF1R and IR expression and localisation in adrenocortical carcinomasRosa Catalano, Emma Nozza, Barbara Altieri, et al.
Cancers|November 27, 2021
A Multicenter Epidemiological Study on Second Malignancy in Non-Syndromic Pheochromocytoma/Paraganglioma Patients in ItalyLetizia Canu, Soraya Puglisi, Paola Berchialla, et al.
JAMA Oncology|July 12, 2019
Value of Molecular Classification for Prognostic Assessment of Adrenocortical CarcinomaGuillaume Assié, Anne Jouinot, Martin Fassnacht, et al.
The Journal of Clinical Endocrinology and Metabolism|December 15, 2016
DNA Methylation Is an Independent Prognostic Marker of Survival in Adrenocortical CancerAnne Jouinot, Guillaume Assie, Rossella Libe, et al.
The Lancet. Diabetes & Endocrinology|August 24, 2023
Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational studyMassimo Terzolo, Martin Fassnacht, Paola Perotti, et al.
Pageof 31